In June of 2018, Bayer AG closed on its acquisition of agri-chemical giant Monsanto. Some news outlets reported a $63 billion acquisition, whereas others reported even higher acquisition costs after closing (Bloomberg reported $66 billion). Naturally, Bayer eyed significant profits from the acquisition, even if intended to bolster public relations by doing away with the Monsanto name. If Bayer aimed…